A clinical stage medical device company developing a novel catheter based mapping system used for guiding cardiac ablation procedures for the treatment of arrhythmias like atrial fibrillation

Sectors
Healthcare
Life Sciences
First Invested
2013
Early
Company Status
Acquired
Acquired by Abbott Labs